Arkansas has temporarily suspended enforcement of the nation’s first state law to address pharmaceutical manufacturer denials of 340B pricing on drugs when they are dispensed by contract pharmacies.
State Insurance Commissioner Alan McClain ordered the 90-day suspension on July 29. The new law’s 340B provisions were slated to take effect on July 28. In his order, McClain said Pharmaceutical Research and Manufacturers of America (PhRMA) asked him on July 29 to rule on whether the law’s 340B provisions violate the U.S. Constitution.
Arkansas has temporarily suspended enforcement of the nation’s first state law to address pharmaceutical manufacturer denials of 340B pricing on drugs when they are dispensed by contract pharmacies.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
